Anti-tumor effects and cell motility inhibition of the DN604-gemcitabine combined treatment in human bladder cancer models

Bioorganic & Medicinal Chemistry ◽

10.1016/j.bmc.2020.115858 ◽

2020 ◽

pp. 115858

Author(s):

Xinyi Wang ◽

Feihong Chen ◽

Shaohua Gou

Keyword(s):

Bladder Cancer ◽

Cell Motility ◽

Combined Treatment ◽

Human Bladder Cancer ◽

Human Bladder ◽

Cancer Models ◽

Motility Inhibition

Download Full-text

Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models

Investigational New Drugs ◽

10.1007/s10637-021-01073-x ◽

2021 ◽

Author(s):

Chao Shang ◽

Yi-Long Zhu ◽

Yi-Quan Li ◽

Gao-Jie Song ◽

Chen-Chen Ge ◽

...

Keyword(s):

Bladder Cancer ◽

Human Bladder Cancer ◽

Human Bladder ◽

Download Full-text

SYNERGISTIC INHIBITION OF TUMOR GROWTH AND METASTASIS BY COMBINED TREATMENT WITH TNP-470 AND GEMCITABINE IN A HUMAN BLADDER CANCER KOTCC-1 MODEL

The Journal of Urology ◽

10.1097/01.ju.0000133653.74536.43 ◽

2004 ◽

Vol 172 (4 Part 1) ◽

pp. 1485-1489 ◽

Author(s):

MOTOTSUGU MURAMAKI ◽

HIDEAKI MIYAKE ◽

ISAO HARA ◽

GAKU KAWABATA ◽

SADAO KAMIDONO

Keyword(s):

Bladder Cancer ◽

Tumor Growth ◽

Combined Treatment ◽

Human Bladder Cancer ◽

Human Bladder ◽

Synergistic Inhibition ◽

Inhibition Of Tumor Growth ◽

Tumor Growth And Metastasis

Download Full-text

Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-11-0592 ◽

2011 ◽

Vol 11 (1) ◽

pp. 244-253 ◽

Author(s):

Koji Ueno ◽

Hiroshi Hirata ◽

Shahana Majid ◽

Soichiro Yamamura ◽

Varahram Shahryari ◽

...

Keyword(s):

Bladder Cancer ◽

Tumor Suppressor ◽

Cell Motility ◽

Cancer Cells ◽

Human Bladder Cancer ◽

Human Bladder ◽

Migration Ability ◽

Bladder Cancer Cells ◽

And Migration ◽

Human Bladder Cancer Cells

Download Full-text

SYNERGISTIC ANTITUMOR ACTIVITY BY COMBINED TREATMENT WITH GEMCITABINE AND ANTISENSE OLIGODEOXYNUCLEOTIDE TARGETING CLUSTERIN GENE IN AN INTRAVESICAL ADMINISTRATION MODEL AGAINST HUMAN BLADDER CANCER KOTCC-1 CELLS

The Journal of Urology ◽

10.1097/01.ju.0000118382.89456.f7 ◽

2004 ◽

Vol 171 (6 Part 1) ◽

pp. 2477-2481 ◽

Author(s):

HIDEAKI MIYAKE ◽

HIROSHI ETO ◽

ISAO HARA ◽

ALAN SO ◽

DANBIN LI ◽

...

Keyword(s):

Bladder Cancer ◽

Antitumor Activity ◽

Combined Treatment ◽

Antisense Oligodeoxynucleotide ◽

Human Bladder Cancer ◽

Intravesical Administration ◽

Human Bladder ◽

Synergistic Antitumor Activity

Download Full-text

Abstract 182: Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by down-regulating RhoC and FZD4

10.1158/1538-7445.am2012-182 ◽

2012 ◽

Author(s):

Koji Ueno ◽

Hiroshi Hirata ◽

Shahana Majid ◽

Soichiro Yamamura ◽

Varahram Shahryari ◽

...

Keyword(s):

Bladder Cancer ◽

Tumor Suppressor ◽

Cell Motility ◽

Cancer Cells ◽

Human Bladder Cancer ◽

Human Bladder ◽

Migration Ability ◽

Bladder Cancer Cells ◽

And Migration ◽

Human Bladder Cancer Cells

Download Full-text

Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells

Yonsei Medical Journal ◽

10.3349/ymj.2020.61.7.587 ◽

2020 ◽

Vol 61 (7) ◽

pp. 587

Author(s):

Hyung Joon Kim ◽

Mi Kyung Gong ◽

Cheol Yong Yoon ◽

Jaeku Kang ◽

Mijin Yun ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Cells ◽

Combined Treatment ◽

Hsp90 Inhibitor ◽

Human Bladder Cancer ◽

Antitumor Effects ◽

Human Bladder ◽

Dual Inhibitor ◽

Bladder Cancer Cells ◽

Human Bladder Cancer Cells

Download Full-text

766: Synergistic Inhibition of Tumor Growth and Metastasis by Combined Treatment with an Antiangiogenic Agent TNP-470 and Gemcitabine in a Human Bladder Cancer KoTCC-1 Model

The Journal of Urology ◽

10.1016/s0022-5347(18)34935-8 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 208-208

Author(s):

Mototsugu Muramaki ◽

Hideaki Miyake ◽

Isao Hara ◽

Sadao Kamidono

Keyword(s):

Bladder Cancer ◽

Tumor Growth ◽

Combined Treatment ◽

Antiangiogenic Agent ◽

Human Bladder Cancer ◽

Human Bladder ◽

Synergistic Inhibition ◽

Inhibition Of Tumor Growth ◽

Tumor Growth And Metastasis

Download Full-text

Abstract P245: Synergistic effect of combination of pemigatinib with enfortumab vedotin (EV) in human bladder cancer models

10.1158/1535-7163.targ-21-p245 ◽

2021 ◽

Author(s):

Rodrigo A. Hess ◽

Lisa Truong ◽

Antony Chadderton ◽

Michelle Frascella ◽

Leslie Hall ◽

...

Keyword(s):

Bladder Cancer ◽

Synergistic Effect ◽

Human Bladder Cancer ◽

Human Bladder ◽

Download Full-text

971 COMBINED TREATMENT WITH CISPLATIN AND DUAL PI3K-MTOR INHIBITOR NVP-BEZ235 CAN RESTORE CASPASE DEPENDENT APOPTOSIS IN CISPLATIN RESISTANT HUMAN BLADDER CANCER CELL THROUGH THE DOWN-REGULATION OF C-FLIP

The Journal of Urology ◽

10.1016/j.juro.2010.02.1918 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Cheol Yong Yoon ◽

Mi Jung Park ◽

Seung Whan Doo ◽

Hong Zoo Park ◽

Dae Sung Kim ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Cell ◽

Mtor Inhibitor ◽

Combined Treatment ◽

Bladder Cancer Cell ◽

Human Bladder Cancer ◽

Down Regulation ◽

Human Bladder ◽

Human Bladder Cancer Cell

Download Full-text

1,25D3 Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models

Cancer ◽

10.1002/cncr.25059 ◽

2010 ◽

Vol 116 (13) ◽

pp. 3294-3303 ◽

Author(s):

Yingyu Ma ◽

Wei-Dong Yu ◽

Donald L. Trump ◽

Candace S. Johnson

Keyword(s):

Bladder Cancer ◽

Antitumor Activity ◽

Human Bladder Cancer ◽

Human Bladder ◽

Cancer Models ◽

Gemcitabine And Cisplatin

Download Full-text